Menu
April 30, 2021

Devastating Outcomes in Pregnant and Lactating Women Following Experimental COVID Vaccines

Overview

Today’s article contains a troubling VAERS report of a breastfed 5-month-old boy who died the day after his mother received her second Pfizer COVID vaccine. Exploration of thrombocytopenia —both immune thrombocytopenia purpura (ITP) and thrombotic thrombocytopenia purpura (TTP) —potentially life-threatening and even fatal disorders reported in some recipients of COVID vaccines. We view the latest US VAERS, UK Yellow Card, and European EudraVigilance data reports on incidence of thrombocytopenia following experimental COVID vaccinations and rising numbers of “red flag” cases of premature labor, miscarriage, and fetal death trigger escalating concerns about COVID vaccines in pregnancy; latest VAERS, UK, and European data on pregnancy-related adverse outcomes.

 

By Dawn Amittai

 

Deeply Troubling VAERS Report of Breastfed Baby Dying the Day After Mother Receives Second Pfizer COVID Vaccine

Where is the scientific evidence that it is safe for pregnant and lactating woman to get the COVID shot? The current guidelines from the American College of Obstetricians and Gynecologists (ACOG) for breastfeeding women are: “COVID-19 vaccines should be offered to lactating individuals similar to non-lactating individuals.” CDC guidelines for breastfeeding mothers taking COVID vaccines are: “The COVID-19 vaccines authorized now are non-replicating vaccines, meaning they are able to create an immune response but do not reproduce inside host cells. Because non-replicating vaccines pose no risk for lactating people or their infants, COVID-19 vaccines are also thought to not be a risk to the breastfeeding infant. Therefore, lactating people may choose to be vaccinated.” We do not understand how the COVID shots can legally be called non-replicating, when the very means by which they “work” is to make the recipient’s cells produce (replicate) the spike protein part of the coronavirus.  There was a report from Palm Beach County that an infant was born with COVID-19 antibodies after the mother had been vaccinated. There have even been recent reports in the media encouraging breastfeeding women to get COVID vaccines in the hope that it might transfer immunity to their children.

This week a deeply troubling Vaccine Adverse Event Reporting System (VAERS) report conveyed the story of a breastfed 5-month-old boy who died 24-hours after his mother received her second Pfizer COVID vaccine. The report described the events as they unfolded: on March 17th, the mother received a second Pfizer shot while at work, and the next day her baby was covered in a full body rash, refused to eat, developed fever, and became inconsolable. She brought him to the emergency room, where he was diagnosed with elevated liver enzymes, and thrombotic thrombocytopenic purpura (TTP). He was immediately hospitalized, began various treatments, but continued to decline. He passed away the same night (see baby’s VAERS report).

A search for this case in the media only produced two reports, both of which declared the story “unproven” based upon a Snopes rating (see screen shot).  The second report from a site called “Parentology” reported, “It seems that the people discussing this story online are either in the anti-vaccination camp or simply sharing a fear-based story — as often happens with internet hoaxes.” This was followed by reiterating the practice advisory statement issued by American College of Obstetrics and Gynecology (ACOG) and the advisory statement from Academy of Breastfeeding Medicine (ABM) which includes the following recommendations:

  • “During lactation, it is unlikely that the vaccine lipid would enter the bloodstream and reach breast tissue. If it does, it is even less likely that either the intact nanoparticle or mRNA transfer into milk. In the unlikely event that mRNA is present in milk, it would be expected to be digested by the child and would be unlikely to have any biological effects.
  • While there is little plausible risk for the child, there is a biologically plausible benefit. Antibodies and T-cells stimulated by the vaccine may passively transfer into milk. Antibodies transferred into milk may therefore protect the infant from infection with SARS-CoV-2.”

Cases of thrombocytopenia have been reported to VAERS by some recipients of the experimental COVID vaccines (as well as occurring after some other vaccines). As we mentioned in a recent article (6 of 8), the FDA lists thrombocytopenia as one of the possible adverse event outcomes of COVID-19 vaccines being monitored by the Food and Drug Administration (FDA). In fact, it is included on their COVID-19 Vaccines “DRAFT Working list of possible adverse events outcomes.” (see screenshot)

While reporting an incident of this nature, it is always important to keep the limitations of these governmental vaccine adverse event reporting and tracking systems in mind. The VAERS site displays a disclaimer directly stating, “The number of reports alone cannot be interpreted or used to reach conclusions about the existence, severity, frequency, or rates of problems associated with vaccines… data are subject to limitations of under-reporting, reporting bias, and lack of incidence rates in unvaccinated comparison groups.” In other words, VAERS is not designed to assess causality. Thus, we cannot draw any definite conclusions on the cause of this baby’s death following his mother’s receipt of a second experimental Pfizer shot. However, the timing, the fact that FDA lists such events as “possible adverse events outcomes” on their website, and the fact that cases of thrombocytopenia have been reported to VAERS by some recipients of the COVID vaccines is certainly grounds for profound concern. Could it be possible — despite all the reassurances by ACOG and ABM that the vaccine cannot reach breast tissue and that breastfeeding after COVID vaccination is safe and even possibly beneficial — that this 5-month-old breastfed baby’s death from TTP 24-hours after his mother’s Pfizer vaccine could have been a vaccine injury conferred via breastmilk? What possible implications could this have for babies and young children participating in clinical trials of these experimental COVID vaccines?

With that said, let us first explore thrombocytopenia, so we can cultivate a working understanding of this condition; then we will explore the number of cases reported to the VAERS to date.

Thrombocytopenia is a condition where the blood has lower numbers of platelets, also known as “thrombocytes”, which are the blood cells that form clots to stop bleeding in the body. When there are too few platelets/thrombocytes, mild to life-threatening bleeding can occur; this condition can be fatal, especially if the bleeding is severe or occurs in the brain. There are different types of thrombocytopenia, but for purposes of our discussion, we will explore only two, which are most relevant to our topic: 1) thrombotic thrombocytopenic purpura (TTP) and 2) immune (aka idiopathic) thrombocytopenia purpura/ITP.

TTP is a platelet disorder that results in spontaneous clotting of the small blood vessels, because enzymes vital to stop blood clotting are lacking; the clots interfere with blood flow to the body’s organs. Due to the unconstrained formation of so many blood clots, the body’s supply of platelets becomes overused — now there are lowered thrombocytes AND lowered blood clotting enzymes simultaneously, so we see both blood clots AND bleeding. The bleeding causes purple bruises called “purpura”, and those with this condition commonly develop bleeding under the skin which may appear like a rash, with tiny red or purple dots on the skin called “petechiae”. Severe symptoms may involve the brain — such as brain damage or a stroke — and can become chronic or fatal.

ITP is a platelet disorder usually caused by an autoimmune response, where the body’s immune system attacks and destroys its own platelets. The resultant low number of platelets will not allow the blood to clot as it should, causing internal bleeding or bleeding underneath the skin. When this happens, bruises (i.e., purpura) appear on the skin or mucous membranes (e.g., in the mouth), nosebleeds may occur, women may have heavier menstrual bleeding than usual, and, as in TTP, bleeding under the skin appearing like a rash with tiny red or purple dots called petechiae. ITP can be self-limiting (i.e., goes away on its own in weeks or months), can become chronic and last years, can be mild to life-threatening — and even fatal, especially if bleeding occurs in the brain. An example (detailed in a previous article 6 of 9) of this scenario is Dr. Gregory Michael, a 56-year-old Miami obstetrician who died from ITP following a brain hemorrhage two weeks after receiving Pfizer’s COVID-19 experimental vaccine late last year.

***

Next, we will explore the total number of cases of thrombocytopenia — including both ITP and TTP — reported to the VAERS following the administration of the three experimental COVID vaccines to date. As always, it is good to remember, the number of cases reported to VAERS represents only 1% of all the actual vaccine adverse events and 1-13% of serious adverse events/deaths  (see VAERS data):

Thrombocytopenia-Related Adverse Events Reported to VAERS by April 23, 2021 for Pfizer, Moderna, and J&J’s COVID-19 Vaccines: 220* cases

 The breakdown of cases of all types of thrombocytopenia reported to VAERS listed by COVID vaccine manufacturer is:

  • 124* thrombocytopenia-related events were reported to VAERS after Pfizer injections
  • 91* thrombocytopenia-related cases were reported to VAERS after Moderna shots
  • 37* thrombocytopenia-related cases were reported to VAERS after J&J jabs
  • Permanent disability: A separate search of VAERS data showed that 6 of the 220 total cases resulted in permanent disability — it is likely that many of these reported injury cases are still unresolved or the outcomes are not yet known.

*Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table; this is the reason why this report from VAERS shows the total count is greater than 220 and the total percentage is greater than 100.

 Thrombocytopenia-Related Deaths Reported to VAERS by April 23, 2021 for Pfizer, Moderna, and J&J’s COVID-19 Vaccines: 24* cases.

We also ran a separate query, which showed 24* of the 220 who developed thrombocytopenia following receipt of one of the experimental COVID vaccines died.

The breakdown of reported cases of all types of thrombocytopenia which resulted in death listed by COVID vaccine manufacturer is:

  • 18* of these deaths followed Pfizer/BioNTech shots
  • 9* who died had received Moderna jabs
  • 3* of the deaths was a J&J vaccine recipient

*Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table; this is the reason why this report from VAERS shows the total count is greater than 220 and the total percentage is greater than 100.

Some case descriptions of thrombocytopenia following administration of COVID vaccines posted on VAERS are:

  • 22-year-old male from Wisconsin with no preexisting health issues: “: Patient received Pfizer COVID 19 vaccine last Thursday 12/17. Admitted today (12/21) with bleeding and low platelet count – working up for ITP, TTP. Given recency of vaccination and no known contributory allergy or medical history, physician thought potentially associated with vaccination.”
  • 36-year-old female from Pennsylvania with no preexisting conditions: “starting to feel lethargic and weak. Had menses with increased blessed. Called physician to have blood work done to see if I was experiencing anemia. Bloodwork completed on 12/31/2020. On 1/3/2021, I woke up with blood blisters all over the inside of my mouth and petechia on my trunk and bilateral upper and lower extremities. I called my primary physician to report the symptoms. He suggested to go to the ER if my symptoms worsened. Later that evening I started with a nosebleed and did go to the ER. Upon arrival to the ER, my platelet count was 9. I was admitted to the hospital and diagnosed with ITP.”
  • 25-year-old female from Washington: “Severe thrombocytopenia (plts 3k/uL), oral mucosal bleeding, bruising.”
  • 43-year-old female from Massachusetts with no significant medical history: “Severe thrombocytopenia (platelet count 2,000) 8 days following Moderna COVID vaccine. Clinically suspicious for ITP.”
  • 38-year-old male from Oklahoma: “Pt is currently hospitalized under my care with new onset thrombocytopenia, with platelets at 19,000. He has abdominal pain, nausea and vomiting, and diaphoresis with chills. No symptomatic bleeding at this time. Did admit to nosebleed a few days prior to admission.”

Next, we searched VAERS for cases of ITP and TTP reported of as of April 16, 2021— the results follow. As always, let us remember that the number of cases reported to VAERS represents only 1% of all the actual vaccine adverse events and 1-13% of serious adverse events/deaths  (see VAERS data):

ITP-Related Cases Reported to VAERS by April 23, 2021 for Pfizer, Moderna, and J&J’s COVID-19 Vaccines: 83* cases

The breakdown of ITP cases reported to VAERS by vaccine manufacturer is:

  • 44* followed Pfizer shots
  • 38* had received Moderna jabs
  • 10* were J&J vaccine recipients
  • Deaths: We also ran a separate query which showed 3 of the 83 vaccine recipients who experienced ITP died (2 following Moderna’s COVID jabs, and 1 following Pfizer’s).

*Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table; this is the reason why this report from VAERS shows the total count is greater than 83 and the total percentage is greater than 100.  

TTP-Related Cases Reported to VAERS by April 23, 2021 for Pfizer, Moderna, and J&J’s COVID-19 Vaccines: 10* cases.

The breakdown of TTP cases by vaccine manufacturer showed that 1 was a J&J vaccine recipient, 1 had taken the Moderna shot, and the remainder had received the Pfizer jab.

TTP-Related Deaths Reported to VAERS by April 23, 2021 for Pfizer, Moderna, and J&J’s COVID-19

 Vaccines: 4* cases

Deaths:  Our query showed 4* of the 10 vaccine recipients who experienced TTP died; all of them had received Pfizer’s vaccine. Please note that one of the 4 deaths was that of the 5-month-old breastfed baby whose mother received a second Pfizer vaccine the day prior to his death.

*Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table; this is the reason why this report from VAERS shows the total count is greater than 10 and the total percentage is greater than 100.

 ***

 

Continuing our Focus on the Use of Experimental COVID Vaccines in Pregnancy: Adverse Pregnancy Outcomes Continue to Rise

In our last few articles, we reflected on how the WHOCDC and the Advisory Committee on Immunization Practices (ACIP), Dr. Fauci, and ACOG all suddenly dismissed their previous concerns about women receiving these experimental COVID vaccines during pregnancy, despite the fact that none of them have ever been tested in pregnant women. In fact, ACOG’s website page, “Vaccinating Pregnant and Lactating Patients Against COVID-19” was updated April 28, 2021, and highlights of current recommendations state:

  • “ACOG recommends that pregnant individuals have access to COVID-19 vaccines.”
  • “COVID-19 vaccines should be offered to lactating individuals similar to non-lactating individuals.”
  • “Individuals considering a COVID-19 vaccine should have access to available information about the safety and efficacy of the vaccine…”

So, what are these recently revised lenient guidelines based upon? Are these health experts aware of the mounting hard evidence of adverse pregnancy outcomes following COVID vaccine exposure?  Why do they continue to ignore so many red flags? If ACOG is advocating potential vaccine recipients should have access to safety and efficacy information about the vaccine, why are we not providing information — either in the media or provided in a written informed consent listing concerns about recent adverse outcomes seen in VAERS data providing adverse outcomes, such as premature labor, miscarriage, and fetal deaths?

We repeated a VAERS search on this same topic, which revealed that adverse pregnancy outcome cases reported and uploaded since our last article which utilized VAERS data through February 26th,  2021 had increased from 51 to 160 cases by April 23, 2021 — an increase of 109 cases in VAERS over 8 weeks — nearly 14 adverse pregnancy-related cases every week. As always, it is helpful to keep in mind that these numbers represent fewer than 1% of all the actual vaccine adverse events and only 1-13% of serious events/death are reported… which means, this could even be as high as an increase of over 10,900 adverse pregnancy outcomes in the past 8 weeks (see VAERS report findings).

Pregnancy-Related Adverse Events Reported to VAERS by April 23, 2021 for Pfizer, Moderna, and J&J’s COVID-19 Vaccines: 160* cases

The breakdown of cases of adverse pregnancy-related cases reported to VAERS listed by COVID vaccine manufacturer is:

  • 108* of these cases followed Pfizer shots
  • 74* had received Moderna jabs
  • 17* were J&J vaccine recipients

*Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table; this is the reason why this report from VAERS shows the total count is greater than 160 and the total percentage is greater than 100.

Some cases posted on VAERS are:

  • 34-year-old female from Ohio: “Saw OB on Jan 4 and there was a strong heartbeat and no defects or problems noted in any bloodwork up to that point in the pregnancy. Received my second vaccine on Jan 19. On Feb 3 I went to my next ultrasound appointment and was told that the baby had no heartbeat. It was estimated that the baby had likely passed a couple weeks prior, but I am not certain of the timeline in regard to receiving the second vaccine.”
  • 40-year-old from Kentucky: “Fetal demise sometime between 15-18 weeks based on ultrasound findings. EDC 7/30/2021”
  • 42-year-old female from Pennsylvania: “The evening of my vaccination, I began to feel feverish, weak and achy. During the night I woke with heavy bleeding and found out the following morning I had miscarried my otherwise healthy pregnancy.”
  • 31-year-old female from Pennsylvania: “Miscarriage 8 days after receiving 2nd vaccine at 6 weeks pregnant; receiving 2nd vaccine at 6 weeks pregnant…”
  • 36-year-old female from Michigan: “Premature infant born at hospital after premature labor was found to have injured brain tissue (PVL) on cranial ultrasound after delivery. Timing of the injury coincides with maternal clinical illness after second Covid vaccine, about two weeks prior to delivery. The mother and father asked me whether the Covid vaccine could have contributed to the brain injury. I reassured them that the Covid vaccine is felt to be safe during pregnancy, but that I would report the concern.”
  • 24-year-old female: “At 8 weeks pregnancy (2 weeks after first shot) started bleeding and had a subchorionic hematoma. By 10-week subchorionic hematoma resolved. Received second shot and of Feb. 1 week later, at 12 weeks pregnancy, fetus had no heartbeat! It measured normal size (as expected) and limited normal first trimester anatomy by ultrasound. But NO heartbeat. Something insulted this placenta to lead to fetal demise.”

An Updated Search of UK Yellow Card Data on Adverse Pregnancy-Related Events

We repeated our search of UK Yellow Card data looking at their most recently updated reports (through April 21, 2021), which revealed a total of  114 cases of adverse pregnancy-related events following both Pfizer and AstraZeneca’s vaccines. This reveals an increase of 87 adverse pregnancy outcomes since our previous article on this topic published March 8th, 2021. As we previously mentioned, Public Health UK’s guidelines for use of COVID vaccines in pregnancy issued by the Joint Committee on Vaccination and Immunisation (JCVI) is slightly more conservative than US recommendations (see Yellow Card Scheme data reports):

Pregnancy-Related Adverse Events Reported to UK Yellow Card System by April 21, 2021 for Pfizer’s COVID Vaccine: 64 cases

 

Pregnancy-Related Adverse Events Reported to UK’s Yellow Card System by April 21, 2021 for AstraZeneca’s COVID Vaccine: 50 cases

 

An Updated Search of European EudraVigilance Data on Adverse Pregnancy-Related Events

Next, we repeated our search of pregnancy-related adverse events reported to the European EudraVigilance System by April 24th for AstraZeneca, Pfizer and Moderna’s experimental COVID vaccines. These three reports reveal a cumulative total of 356 cases (see EudraVigilance data):

Pregnancy-Related Adverse Events Reported to European EudraVigilance System by April 24, 2021 for AstraZeneca’s COVID Vaccine: 111 cases


Pregnancy-Related Adverse Events Reported to European EudraVigilance System by April 24, 2021 for Pfizer’s COVID Vaccine: 195 cases   

Pregnancy-Related Adverse Events Reported to European EudraVigilance System by April 24, 2021 for Moderna’s COVID Vaccine: 50 cases

Since our last report on this theme last month, there has been a significant increase in adverse pregnancy-related outcomes of premature labor, miscarriage, and fetal deaths reported here in the US, in UK, and in Europe. As always, keep in mind that these reported events likely represent a small percentage of what the actual numbers likely are.

Are these rising numbers of documented cases we have just reported not conspicuous evidence of a deeply concerning issue that is not being addressed? Why does it appear that our public health experts and regulatory agencies — CDC and the ACIP, WHO, Dr. Fauci, and ACOG — have turned a blind eye on these rising numbers of red flag cases? Why are they continuing to encourage pregnant and lactating women to expose themselves and their babies to these experimental, warp-speed produced COVID vaccines?

***

This article contains a growing list of deaths and serious injuries that occurred after the experimental COVID vaccine was administered. The death and serious injury reports are culled from the media, as well as from the CDC’s Vaccine Adverse Event Reporting System (VAERS) and reporting systems outside the US. Although the deaths and serious injuries are temporally related to the COVID vaccination, Children’s Health Defense – California Chapter cannot claim the COVID vaccine definitively caused the deaths or serious injuries. That said, the symptom patterns and timing are highly suspicious, and tend to follow patterns of adverse events widely recognized to occur after other vaccinations. The death reports serve as anecdotes that may soon establish a pattern. Children’s Health Defense – California Chapter is providing regular updates on newly reported deaths that occur after COVID vaccination. As always, Children’s Health Defense – California Chapter supports fully informed consent and no medical mandates. This is not medical advice. Please share this information with, and consult your doctor.